SEATTLE, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering single-molecule proteome analysis, today announced the launch of an Early ...
• Baylor selects the Nautilus Voyager™ Platform, now available through Early Access Program, for development of a first-in-class computational multi-omics toolkit • NIH-funded project leverages ...
Sujal Patel, Co-Founder and CEO, highlighted the public unveiling of the Nautilus Voyager instrument at the US Human Proteome Organization Conference, calling it a "key highlight" and noting, "The ...
Early Access Program participants receive exclusive use of Nautilus’ Iterative Mapping method, initially through a validated tau proteoforms assay, with the potential to accelerate Alzheimer’s and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results